Singapore markets closed
Straits Times Index
3,410.81 -29.07 (-0.85%) Nikkei
40,912.37 -1.28 (-0.00%) Hang Seng
17,799.61 -228.67 (-1.27%) FTSE 100
8,203.93 -37.33 (-0.45%) Bitcoin USD
57,324.42 +584.04 (+1.03%) CMC Crypto 200
1,190.05 -18.65 (-1.54%)
MRNA Aug 2024 130.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:09AM EDT. Market open.
| Previous close | 3.7700 |
| Open | 3.4500 |
| Bid | 3.3000 |
| Ask | 4.4500 |
| Strike | 130.00 |
| Expiry date | 2024-08-09 |
| Day's range | 3.4500 - 3.4500 |
| Contract range | N/A |
| Volume | |
| Open interest | 7 |
ZacksBiotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
GSK and CureVac (CVAC) are in the spotlight following a restructuring of their vaccine agreement.
Barrons.comGSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
CureVac is also eligible for future royalties. CureVac shares jumped 12% in early trading Wednesday, while GSK’s American depositary receipt slipped 0.2%. Shares of Moderna a leading mRNA vaccine manufacturer, were up 0.9%.
ZacksModerna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
Moderna (MRNA) expects this funding to help support the development of its mRNA-based pre-pandemic vaccine against the H5 influenza virus, which is responsible for causing avian influenza or bird flu.
© 2024 Yahoo. All rights reserved.